India Keeps Eye On SGLT2 Inhibitors Amid Safety Signals

 
• By Anju Ghangurde
  
Diabetes
PATIENT DATA PERTAINING TO SGLT2 INHIBITORS ARE TO BE EXAMINED IN INDIA
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet